140 related articles for article (PubMed ID: 31336132)
1. Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells.
Chen YR; Chen YS; Chin YT; Li ZL; Shih YJ; Yang YSH; ChangOu CA; Su PY; Wang SH; Wu YH; Chiu HC; Lee SY; Liu LF; Whang-Peng J; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2019 Oct; 132():110693. PubMed ID: 31336132
[TBL] [Abstract][Full Text] [Related]
2. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Ho Y; Wu CY; Chin YT; Li ZL; Pan YS; Huang TY; Su PY; Lee SY; Crawford DR; Su KW; Chiu HC; Shih YJ; Changou CA; Yang YSH; Whang-Peng J; Chen YR; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2020 Feb; 136():111092. PubMed ID: 31883986
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells.
Chin YT; Wei PL; Ho Y; Nana AW; Changou CA; Chen YR; Yang YS; Hsieh MT; Hercbergs A; Davis PJ; Shih YJ; Lin HY
Endocr Relat Cancer; 2018 May; 25(5):533-545. PubMed ID: 29555649
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol induces sumoylated COX-2-dependent anti-proliferation in human prostate cancer LNCaP cells.
Cheng TM; Chin YT; Ho Y; Chen YR; Yang YN; Yang YC; Shih YJ; Lin TI; Lin HY; Davis PJ
Food Chem Toxicol; 2018 Feb; 112():67-75. PubMed ID: 29242151
[TBL] [Abstract][Full Text] [Related]
6. Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers.
Yang YSH; Li ZL; Shih YJ; Bennett JA; Whang-Peng J; Lin HY; Davis PJ; Wang K
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817534
[No Abstract] [Full Text] [Related]
7. Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
Lin SJ; Chin YT; Ho Y; Chou SY; Sh Yang YC; Nana AW; Su KW; Lim YT; Wang K; Lee SY; Shih YJ; Chen YR; Whang-Peng J; Davis PJ; Lin HY; Fu E
Food Chem Toxicol; 2018 Oct; 120():1-11. PubMed ID: 29960019
[TBL] [Abstract][Full Text] [Related]
8. Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.
Pradhan R; Paul S; Acharya SS; Sinha S; Dash SR; Kundu CN
J Nutr Biochem; 2024 Mar; 125():109568. PubMed ID: 38185347
[TBL] [Abstract][Full Text] [Related]
9. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells.
Lin CC; Chin YT; Shih YJ; Chen YR; Chung YY; Lin CY; Hsiung CN; Whang-Peng J; Lee SY; Lin HY; Davis PJ; Wang K
J Dent Sci; 2019 Sep; 14(3):255-262. PubMed ID: 31528253
[TBL] [Abstract][Full Text] [Related]
11. Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
Nana AW; Chin YT; Lin CY; Ho Y; Bennett JA; Shih YJ; Chen YR; Changou CA; Pedersen JZ; Incerpi S; Liu LF; Whang-Peng J; Fu E; Li WS; Mousa SA; Lin HY; Davis PJ
Endocr Relat Cancer; 2018 Mar; 25(3):279-293. PubMed ID: 29255096
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated.
Lin HY; Tang HY; Keating T; Wu YH; Shih A; Hammond D; Sun M; Hercbergs A; Davis FB; Davis PJ
Carcinogenesis; 2008 Jan; 29(1):62-9. PubMed ID: 17984113
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells.
Lin HY; Sun M; Tang HY; Simone TM; Wu YH; Grandis JR; Cao HJ; Davis PJ; Davis FB
J Cell Biochem; 2008 Aug; 104(6):2131-42. PubMed ID: 18446786
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells.
Lin HY; Shih A; Davis FB; Davis PJ
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):427-32. PubMed ID: 10024519
[TBL] [Abstract][Full Text] [Related]
15. Inducible COX-2-dependent apoptosis in human ovarian cancer cells.
Lin C; Crawford DR; Lin S; Hwang J; Sebuyira A; Meng R; Westfall JE; Tang HY; Lin S; Yu PY; Davis PJ; Lin HY
Carcinogenesis; 2011 Jan; 32(1):19-26. PubMed ID: 21187340
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation.
Yun KJ; Koh DJ; Kim SH; Park SJ; Ryu JH; Kim DG; Lee JY; Lee KT
J Agric Food Chem; 2008 Nov; 56(21):10265-72. PubMed ID: 18841975
[TBL] [Abstract][Full Text] [Related]
17. The pro-apoptotic action of stilbene-induced COX-2 in cancer cells: convergence with the anti-apoptotic effect of thyroid hormone.
Lin HY; Davis PJ; Tang HY; Mousa SA; Luidens MK; Hercbergs AH; Davis FB
Cell Cycle; 2009 Jun; 8(12):1877-82. PubMed ID: 19440051
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of nonpeptide hormones on resveratrol-induced antiproliferation of cancer cells.
Lin HY; Hsieh MT; Cheng GY; Lai HY; Chin YT; Shih YJ; Nana AW; Lin SY; Yang YSH; Tang HY; Chiang IJ; Wang K
Ann N Y Acad Sci; 2017 Sep; 1403(1):92-100. PubMed ID: 28759712
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone and anti-apoptosis in tumor cells.
Lin HY; Glinsky GV; Mousa SA; Davis PJ
Oncotarget; 2015 Jun; 6(17):14735-43. PubMed ID: 26041883
[TBL] [Abstract][Full Text] [Related]
20. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
